BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 33913468)

  • 1. Deficiency of myeloid PHD proteins aggravates atherogenesis via macrophage apoptosis and paracrine fibrotic signalling.
    van Kuijk K; Demandt JAF; Perales-Patón J; Theelen TL; Kuppe C; Marsch E; de Bruijn J; Jin H; Gijbels MJ; Matic L; Mees BME; Reutelingsperger CPM; Hedin U; Biessen EAL; Carmeliet P; Baker AH; Kramann RK; Schurgers LJ; Saez-Rodriguez J; Sluimer JC
    Cardiovasc Res; 2022 Mar; 118(5):1232-1246. PubMed ID: 33913468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid PHD2 Conditional Knockout Improves Intraplaque Angiogenesis and Vascular Remodeling in a Murine Model of Venous Bypass Grafting.
    Sluiter TJ; Tillie RJHA; de Jong A; de Bruijn JBG; Peters HAB; van de Leijgraaf R; Halawani R; Westmaas M; Starink LIW; Quax PHA; Sluimer JC; de Vries MR
    J Am Heart Assoc; 2024 Feb; 13(3):e033109. PubMed ID: 38258662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-Inducible Factor-1α Expression in Macrophages Promotes Development of Atherosclerosis.
    Aarup A; Pedersen TX; Junker N; Christoffersen C; Bartels ED; Madsen M; Nielsen CH; Nielsen LB
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1782-90. PubMed ID: 27444197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid PHD2 deficiency accelerates neointima formation via Hif-1α.
    Christoph M; Pfluecke C; Mensch M; Augstein A; Jellinghaus S; Ende G; Mierke J; Franke K; Wielockx B; Ibrahim K; Poitz DM
    Mol Immunol; 2022 Sep; 149():48-58. PubMed ID: 35724581
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Fang S; Sun S; Cai H; Zou X; Wang S; Hao X; Wan X; Tian J; Li Z; He Z; Huang W; Liang C; Zhang Z; Yang L; Tian J; Yu B; Sun B
    Theranostics; 2021; 11(19):9358-9375. PubMed ID: 34646375
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypoxia is present in murine atherosclerotic plaques and has multiple adverse effects on macrophage lipid metabolism.
    Parathath S; Mick SL; Feig JE; Joaquin V; Grauer L; Habiel DM; Gassmann M; Gardner LB; Fisher EA
    Circ Res; 2011 Oct; 109(10):1141-52. PubMed ID: 21921268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of hypoxia in murine atherosclerosis prevents necrotic core expansion by enhancing efferocytosis.
    Marsch E; Theelen TL; Demandt JA; Jeurissen M; van Gink M; Verjans R; Janssen A; Cleutjens JP; Meex SJ; Donners MM; Haenen GR; Schalkwijk CG; Dubois LJ; Lambin P; Mallat Z; Gijbels MJ; Heemskerk JW; Fisher EA; Biessen EA; Janssen BJ; Daemen MJ; Sluimer JC
    Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2545-53. PubMed ID: 25256233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficiency of the T cell regulator Casitas B-cell lymphoma-B aggravates atherosclerosis by inducing CD8+ T cell-mediated macrophage death.
    Seijkens TTP; Poels K; Meiler S; van Tiel CM; Kusters PJH; Reiche M; Atzler D; Winkels H; Tjwa M; Poelman H; Slütter B; Kuiper J; Gijbels M; Kuivenhoven JA; Matic LP; Paulsson-Berne G; Hedin U; Hansson GK; Nicolaes GAF; Daemen MJAP; Weber C; Gerdes N; de Winther MPJ; Lutgens E
    Eur Heart J; 2019 Jan; 40(4):372-382. PubMed ID: 30452556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloid CD40 deficiency reduces atherosclerosis by impairing macrophages' transition into a pro-inflammatory state.
    Bosmans LA; van Tiel CM; Aarts SABM; Willemsen L; Baardman J; van Os BW; Toom MD; Beckers L; Ahern DJ; Levels JHM; Jongejan A; Moerland PD; Verberk SGS; den Bossche JV; de Winther MMPJ; Weber C; Atzler D; Monaco C; Gerdes N; Shami A; Lutgens E
    Cardiovasc Res; 2023 May; 119(5):1146-1160. PubMed ID: 35587037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myeloid cell-specific Irf5 deficiency stabilizes atherosclerotic plaques in Apoe
    Leipner J; Dederichs TS; von Ehr A; Rauterberg S; Ehlert C; Merz J; Dufner B; Hoppe N; Krebs K; Heidt T; von Zur Muehlen C; Stachon P; Ley K; Wolf D; Zirlik A; Bode C; Hilgendorf I; Härdtner C
    Mol Metab; 2021 Nov; 53():101250. PubMed ID: 33991749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing Myeloid Netrin-1 Induces Inflammation Resolution and Plaque Regression.
    Schlegel M; Sharma M; Brown EJ; Newman AAC; Cyr Y; Afonso MS; Corr EM; Koelwyn GJ; van Solingen C; Guzman J; Farhat R; Nikain CA; Shanley LC; Peled D; Schmidt AM; Fisher EA; Moore KJ
    Circ Res; 2021 Aug; 129(5):530-546. PubMed ID: 34289717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid A disintegrin and metalloproteinase domain 10 deficiency modulates atherosclerotic plaque composition by shifting the balance from inflammation toward fibrosis.
    van der Vorst EP; Jeurissen M; Wolfs IM; Keijbeck A; Theodorou K; Wijnands E; Schurgers L; Weber S; Gijbels MJ; Hamers AA; Dreymueller D; Rose-John S; de Winther MP; Ludwig A; Saftig P; Biessen EA; Donners MM
    Am J Pathol; 2015 Apr; 185(4):1145-55. PubMed ID: 25659879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. XBP1-mediated activation of the STING signalling pathway in macrophages contributes to liver fibrosis progression.
    Wang Q; Bu Q; Liu M; Zhang R; Gu J; Li L; Zhou J; Liang Y; Su W; Liu Z; Wang M; Lian Z; Lu L; Zhou H
    JHEP Rep; 2022 Nov; 4(11):100555. PubMed ID: 36185574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NecroX-7 reduces necrotic core formation in atherosclerotic plaques of Apoe knockout mice.
    Grootaert MOJ; Schrijvers DM; Van Spaendonk H; Breynaert A; Hermans N; Van Hoof VO; Takahashi N; Vandenabeele P; Kim SH; De Meyer GRY; Martinet W
    Atherosclerosis; 2016 Sep; 252():166-174. PubMed ID: 27425215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tenascin-c renders a proangiogenic phenotype in macrophage via annexin II.
    Wang Z; Wei Q; Han L; Cao K; Lan T; Xu Z; Wang Y; Gao Y; Xue J; Shan F; Feng J; Xie X
    J Cell Mol Med; 2018 Jan; 22(1):429-438. PubMed ID: 28857429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SM22α (Smooth Muscle Protein 22-α) Promoter-Driven IGF1R (Insulin-Like Growth Factor 1 Receptor) Deficiency Promotes Atherosclerosis.
    Sukhanov S; Higashi Y; Shai SY; Snarski P; Danchuk S; D'Ambra V; Tabony M; Woods TC; Hou X; Li Z; Ozoe A; Chandrasekar B; Takahashi SI; Delafontaine P
    Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2306-2317. PubMed ID: 30354209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency of Dab2 (Disabled Homolog 2) in Myeloid Cells Exacerbates Inflammation in Liver and Atherosclerotic Plaques in LDLR (Low-Density Lipoprotein Receptor)-Null Mice-Brief Report.
    Adamson SE; Polanowska-Grabowska R; Marqueen K; Griffiths R; Angdisen J; Breevoort SR; Schulman IG; Leitinger N
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1020-1029. PubMed ID: 29599136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted invalidation of SR-B1 in macrophages reduces macrophage apoptosis and accelerates atherosclerosis.
    Galle-Treger L; Moreau M; Ballaire R; Poupel L; Huby T; Sasso E; Troise F; Poti F; Lesnik P; Le Goff W; Gautier EL; Huby T
    Cardiovasc Res; 2020 Mar; 116(3):554-565. PubMed ID: 31119270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloid LXR (Liver X Receptor) Deficiency Induces Inflammatory Gene Expression in Foamy Macrophages and Accelerates Atherosclerosis.
    Endo-Umeda K; Kim E; Thomas DG; Liu W; Dou H; Yalcinkaya M; Abramowicz S; Xiao T; Antonson P; Gustafsson JÅ; Makishima M; Reilly MP; Wang N; Tall AR
    Arterioscler Thromb Vasc Biol; 2022 Jun; 42(6):719-731. PubMed ID: 35477277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of macrophage transcription factor MafB in atherosclerotic plaque stability.
    Hasegawa H; Watanabe T; Kato S; Toshima T; Yokoyama M; Aida Y; Nishiwaki M; Kadowaki S; Narumi T; Honda Y; Otaki Y; Honda S; Shunsuke N; Funayama A; Nishiyama S; Takahashi H; Arimoto T; Shishido T; Miyamoto T; Abe S; Shibata Y; Kubota I
    Atherosclerosis; 2016 Jul; 250():133-43. PubMed ID: 27214395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.